Gradient Investments LLC Organon & Co. Transaction History

Gradient Investments LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$17.45 - $21.96 $506 - $636	-29 Reduced 39.19%	45 $0
Q1 2024 Apr 23, 2024	SELL	$13.78 - $18.8 $3,541 - $4,831	-257 Reduced 77.64%	74 $1,000
Q4 2023 Jan 18, 2024	BUY	$10.95 - $17.32 $142 - $225	13 Added 4.09%	331 $4,000
Q3 2023 Oct 27, 2023	SELL	$16.59 - $23.77 $3,682 - $5,276	-222 Reduced 41.11%	318 $5,000
Q2 2023 Jul 11, 2023	SELL	$19.27 - $24.63 $674 - $862	-35 Reduced 6.09%	540 $11,000
Q1 2023 Apr 17, 2023	SELL	$21.42 - $32.08 $171 - $256	-8 Reduced 1.37%	575 $13,000
Q4 2022 Jan 10, 2023	SELL	$23.31 - $28.61 $3,682 - $4,520	-158 Reduced 21.32%	583 $0
Q3 2022 Oct 14, 2022	SELL	$23.4 - $34.25 $23 - $34	-1 Reduced 0.13%	741 $17,000
Q2 2022 Jul 11, 2022	SELL	$31.66 - $38.9 $918 - $1,128	-29 Reduced 3.76%	742 $25,000
Q1 2022 May 26, 2022	SELL	$30.45 - $39.36 $4,597 - $5,943	-151 Reduced 16.38%	771 $27,000
Q4 2021 Jan 12, 2022	BUY	$28.67 - $37.13 $172 - $222	6 Added 0.66%	922 $28,000
Q3 2021 Oct 18, 2021	SELL	$28.63 - $35.64 $82,483 - $102,678	-2,881 Reduced 75.88%	916 $30,000
Q2 2021 Jul 12, 2021	BUY	$28.45 - $38.0 $108,024 - $144,286	3,797 New	3,797 $115,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.